Hoth Therapeutics Inc. - HOTH Net earnings per share for the last four quarters

Hoth Therapeutics, Inc. (HOTH) - corporate logo

Hoth Therapeutics, Inc. (HOTH) is managed by experienced biotech experts who minimize regulatory risks. The business relies on stable demand in dermatology, which remains independent of economic cycles. The annual percentage growth of EPS TTM demonstrates the actual profit trend, where the 29.10 level reflects the current magnitude. This helps assess the resilience of Hoth Therapeutics, Inc. (HOTH), which protects its market position through unique patents.

HOTH: Hoth Therapeutics Net earnings per share (EPS TTM) 02/11/2024 - 05/28/2026

Financial and market metric breakdowns for Hoth (HOTH)

- current quotes and average value forecast:
Fundamental company valuation:Hoth Therapeutics, Inc. HOTH
Core merchandise of Hoth Therapeutics Inc.

This indicator measures the rate of change in earnings per share over a rolling twelve-month period, allowing for an assessment of the business's actual profitability dynamics without quarterly gaps. By analyzing the rolling EPS YoY change, an investor can determine the growth stage of Hoth Therapeutics, Inc. (HOTH), whose operating expenses are currently limited by standard waste control in contract laboratories.